The Effect of BSE Training on Breast Cancer Knowledge Level and Health Beliefs
Launched by KAHRAMANMARAS SUTCU IMAM UNIVERSITY · Mar 13, 2025
Trial Information
Current as of April 26, 2025
Completed
Keywords
ClinConnect Summary
Methods Objective This study was conducted to evaluate the effect of the training given to women aged 40 and over on breast cancer and BSE using a breast examination simulator on women's breast cancer knowledge levels and health beliefs.
Type of Study This study is a randomised controlled experimental type. The research was conducted with triple blinding method.
The research data were collected by a trained interviewer independent of the researchers. The women in the experimental and control groups were not informed which group they were included in. The data were analysed by a statistici...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Female gender
- • Being 40 years old and above
- • Being at least a primary school graduate
- • Being open to communication
- • Being willing to participate in the study
- Exclusion Criteria:
- • Having a breast cancer diagnosis
- • Having received training from a health care professional on breast cancer or breast self-examination
- • Regular BSE practice
- • Being a health care professional
- • Having a graduation in the health field
About Kahramanmaras Sutcu Imam University
Kahramanmaras Sutcu Imam University is a leading academic institution dedicated to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on multidisciplinary collaboration, the university harnesses the expertise of its faculty and researchers to conduct rigorous studies that address critical health challenges. Committed to ethical standards and scientific integrity, Kahramanmaras Sutcu Imam University aims to contribute valuable insights to the medical community, ultimately enhancing patient care and treatment options.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kahramanmaraş, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported